Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy (Q40626254)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2002

Language	Label	Description	Also known as
English	Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy	scientific article published on October 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Marta Wawrzynowicz-Syczewska

2

object named as

Marta Wawrzynowicz-Syczewska

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Anna Boroń Kaczmarska

4

object named as

Anna Boron-Kaczmarska

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Patricia K Constantini

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Michael Clare

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ian G McFarlane

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Mathew E Cramp

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Peter T Donaldson

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

404-412

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Hepatitis C virus six years on.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

The interrelationship between hepatitis C virus and HLA.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Chronic viral hepatitis and the human genome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Influence of HLA alleles on outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Hepatitis C virus-specific CD4(+) T cells: do they help or damage?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

An investigation of polymorphism in the interleukin-10 gene promoter

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

HLA and disease associations: detecting the strongest association

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

No adjustments are needed for multiple comparisons

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

21 January 2018

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA class II favors clearance of HCV infection and progression of the chronic liver damage

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A polymorphic variation in a putative regulation box of the TNFA promoter region.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic influence on cytokine production and fatal meningococcal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Freely associating

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01553.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0676.2002.01553.X

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40626254&oldid=2050663207"